Literature DB >> 12695821

Wernicke encephalopathy: MR findings and clinical presentation.

Stefan Weidauer1, Michael Nichtweiss, Heinrich Lanfermann, Friedhelm E Zanella.   

Abstract

Wernicke encephalopathy (WE) is a severe neurological disorder caused by vitamin B1 deficiency. The aim of the study was to analyse MRI findings typical for this disease and to evaluate the significance of their correlations with clinical symptoms. Magnetic resonance images and clinical features of 12 patients with WE were analysed. The patients underwent MR imaging within 3-14 days after onset of clinical symptoms. In 7 of 12 patients MR imaging showed symmetrical diencephalic and midbrain lesions. Postcontrast T1-weighted images from 5 of 9 patients examined during the initial 6 days of acute WE showed a subtle enhancement of the mamillary bodies, the tectal plate, the periaqueductal area and the periventricular region of the third ventricle including the paramedian thalamic nuclei. In addition, T2-weighted and fluid-attenuated inversion recovery (FLAIR) images revealed hyperintense signals in these regions (except for 2 patients where the mamillary bodies were normal). Hyperintense lesions on T2-weighted images without any enhancement on postcontrast T1-weighted images were detected in 2 patients by MR imaging performed 11 or 14 days after onset of WE. Patients with hyperintensities on T2-weighted images of the periventricular region of the third ventricle and the paramedian thalamic nuclei had poor recovery from their mental dysfunction. The MR examination in case of WE shows a typical pattern of lesions in 58% of cases. Enhancement of the mamillary bodies, the periventricular region of the third ventricle including the paramedian thalamic nuclei, and the periaqueductal area on postcontrast T1-weighted images can be observed in the initial period after clinical onset of symptoms and are characteristic signs of the acute stage of WE. Hyperintense lesions in the periventricular region and the paramedian thalamic nuclei on T2-weighted and FLAIR images in the subacute stage of WE and enhancement on postcontrast T1-weighted images of the mamillary bodies and the paramedian thalamic nuclei are indicators of poor prognosis despite vitamin B1 substitution.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12695821     DOI: 10.1007/s00330-002-1624-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Assessment of paramedian thalamic infarcts: MR imaging, clinical features and prognosis.

Authors:  Stefan Weidauer; Michael Nichtweiss; Friedhelm E Zanella; Heinrich Lanfermann
Journal:  Eur Radiol       Date:  2004-04-23       Impact factor: 5.315

Review 2.  MR imaging of midbrain pathologies.

Authors:  E Hattingen; S Blasel; M Nichtweiss; F E Zanella; S Weidauer
Journal:  Clin Neuroradiol       Date:  2010-06-09       Impact factor: 3.649

3.  Wernicke's encephalopathy in a patient with rhinopharyngeal carcinoma.

Authors:  Paraskevi Kosta; Persefoni Margariti; Christos Tolis; Vassilos Tsimichodimos; Spyridon Konitsiotis; Maria Argyropoulou
Journal:  J Neurol       Date:  2005-07-20       Impact factor: 4.849

4.  Wernicke encephalopathy and Creutzfeldt-Jakob disease.

Authors:  A Bertrand; J P Brandel; Y Grignon; V Sazdovitch; D Seilhean; B Faucheux; N Privat; J L Brault; A Vital; E Uro-Coste; M Pluot; F Chapon; C A Maurage; F Letournel; H Vespignani; G Place; C F Degos; K Peoc'h; S Haïk; J J Hauw
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

5.  Wernicke's encephalopathy and anabolic steroid drug abuse. Is there any possible relation?

Authors:  P Christopoulos; C Katsanoulas; G Timplalexi; D Lathyris; S Vasiliagkou; E Antoniadou
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

6.  Wernicke's encephalopathy in a patient with gastric carcinoma: a diagnosis not to miss.

Authors:  Chandrashekar Udyavara Kudru; Shivashankara Kaniyoor Nagiri; Sandeep Rao
Journal:  BMJ Case Rep       Date:  2014-03-20

7.  Wernicke's encephalopathy in a patient with nephrotic syndrome.

Authors:  Masashi Nishida; Hisashi Sato; Naho Kobayashi; Masafumi Morimoto; Kenji Hamaoka
Journal:  Eur J Pediatr       Date:  2008-09-17       Impact factor: 3.183

8.  Wernicke's encephalopathy in a patient with acute pancreatitis: unusual cortical involvement and marvelous prognosis.

Authors:  Hong-Wei Cui; Bo-Ai Zhang; Tao Peng; Yu Liu; Yan-Ru Liu
Journal:  Neurol Sci       Date:  2011-09-15       Impact factor: 3.307

9.  Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation.

Authors:  Zsila Sadighi; Noah D Sabin; Randall Hayden; Elizabeth Stewart; Asha Pillai
Journal:  J Child Neurol       Date:  2015-01-06       Impact factor: 1.987

Review 10.  High-dose Parenteral Thiamine in Treatment of Wernicke's Encephalopathy: Case Series and Review of the Literature.

Authors:  Andrew Nishimoto; Justin Usery; John C Winton; Jennifer Twilla
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.